Impact of Stent Graft Design on External Iliac Artery Limb Occlusion Rates After Endovascular Aneurysm Repair: Post-hoc Analysis of a Japanese Multicentre Database.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 08 05 2018
revised: 13 03 2019
accepted: 20 03 2019
pubmed: 15 10 2019
medline: 10 4 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

It was hypothesised that a helical stent with expanded polytetrafluoroethylene (ePTFE) grafts could provide a preventive effect for external iliac artery (EIA) limb occlusion following endovascular aortic aneurysm repair (EVAR). Therefore, a post-hoc analysis of a Japanese multicentre database was conducted to assess the impact of the stent graft design on EIA limb occlusion rates. Patients who underwent EVAR with EIA limb deployment between 2008 and 2016 were evaluated. The stent graft limbs were divided into two groups: group A comprised stent graft limbs made of a helical stent with ePTFE grafts (Excluder; n = 255), and group B comprised stent graft limbs made of a Z stent with polyester grafts (Zenith, Flex and Endurant; n = 173). The main outcome was the incidence of limb occlusion and severe limb stenosis (EIA related limb complications). The risk factors for EIA related limb complications were analysed and the midterm results between groups A and B compared. Fine-Gray generalisation of the proportional hazards model was used after propensity score matching to calculate the hazard ratio (HR). One complication occurred in group A and 10 complications occurred in group B. The risk factors for EIA related limb complications for the entire group were a stent graft limb size ≤10 mm (HR 5.41; p = .01) and inclusion in group B (HR 14.9; p = .009). After propensity matching, group A (n = 159) was matched with group B (n = 159). The cumulative incidence function of EIA related limb complications at five years was 0.66% in group A and 7.8% in group B (HR 8.67; p = .039). Stent graft design can affect limb patency in EIA limb deployment. When EIA limb deployment is necessary for patients with a small EIA, such as Japanese patients, stent graft limbs made of a helical stent with ePTFE should be used to reduce the risk of limb occlusion.

Sections du résumé

OBJECTIVE/BACKGROUND OBJECTIVE
It was hypothesised that a helical stent with expanded polytetrafluoroethylene (ePTFE) grafts could provide a preventive effect for external iliac artery (EIA) limb occlusion following endovascular aortic aneurysm repair (EVAR). Therefore, a post-hoc analysis of a Japanese multicentre database was conducted to assess the impact of the stent graft design on EIA limb occlusion rates.
METHODS METHODS
Patients who underwent EVAR with EIA limb deployment between 2008 and 2016 were evaluated. The stent graft limbs were divided into two groups: group A comprised stent graft limbs made of a helical stent with ePTFE grafts (Excluder; n = 255), and group B comprised stent graft limbs made of a Z stent with polyester grafts (Zenith, Flex and Endurant; n = 173). The main outcome was the incidence of limb occlusion and severe limb stenosis (EIA related limb complications). The risk factors for EIA related limb complications were analysed and the midterm results between groups A and B compared. Fine-Gray generalisation of the proportional hazards model was used after propensity score matching to calculate the hazard ratio (HR).
RESULTS RESULTS
One complication occurred in group A and 10 complications occurred in group B. The risk factors for EIA related limb complications for the entire group were a stent graft limb size ≤10 mm (HR 5.41; p = .01) and inclusion in group B (HR 14.9; p = .009). After propensity matching, group A (n = 159) was matched with group B (n = 159). The cumulative incidence function of EIA related limb complications at five years was 0.66% in group A and 7.8% in group B (HR 8.67; p = .039).
CONCLUSION CONCLUSIONS
Stent graft design can affect limb patency in EIA limb deployment. When EIA limb deployment is necessary for patients with a small EIA, such as Japanese patients, stent graft limbs made of a helical stent with ePTFE should be used to reduce the risk of limb occlusion.

Identifiants

pubmed: 31607678
pii: S1078-5884(19)30205-9
doi: 10.1016/j.ejvs.2019.03.025
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

839-847

Informations de copyright

Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Tsunehiro Shintani (T)

Department of Vascular Surgery, Shizuoka Red Cross Hospital, Shizuoka, Japan.

Hideaki Obara (H)

Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Electronic address: obara.z3@keio.jp.

Kentaro Matsubara (K)

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Keita Hayashi (K)

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Masanori Hayashi (M)

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Shigeshi Ono (S)

Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.

Tatsuya Shimogawara (T)

Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.

Shintaro Shibutani (S)

Department of Vascular Surgery, Saiseikai Yokohamashi Tobu Hospital, Kawasaki, Japan.

Susumu Watada (S)

Department of Surgery, Kawasaki Municipal Hospital, Kawasaki, Japan.

Yasuhito Sekimoto (Y)

Department of Surgery, Tokyo Medical Centre, Tokyo, Japan.

Norio Uchida (N)

Department of Surgery, Mito Red Cross Hospital, Mito, Japan.

Atsunori Asami (A)

Department of Surgery, Saitama Municipal Hospital, Saitama, Japan.

Taku Fujii (T)

Department of Surgery, Saitama Municipal Hospital, Saitama, Japan; Department of Surgery, Hiratsuka City Hospital, Hiratsuka, Japan.

Hirohisa Harada (H)

Department of Surgery, Saiseikai Central Hospital, Tokyo, Japan.

Naoki Fujimura (N)

Department of Surgery, Saiseikai Central Hospital, Tokyo, Japan.

Yasunori Sato (Y)

Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.

Yuko Kitagawa (Y)

Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH